Thomas Müller
Impact in
- Neurology top 0.1%
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Neuroinflammation and Neurodegeneration Mechanisms
- Neurological diseases and metabolism
-
- Nuclear Receptors and Signaling
- Genetic Neurodegenerative Diseases
Papers in
- Neurology 173
- Parkinson's Disease Mechanisms and Treatments 156
- Neurological disorders and treatments 81
- Botulinum Toxin and Related Neurological Disorders 18
-
- Genetic Neurodegenerative Diseases 19
- Nuclear Receptors and Signaling 14
- Co-authors
- W. Kuhn (38 shared papers)H. Przuntek (43 shared papers)Peter Riederer (11 shared papers)Dirk Woitalla (37 shared papers)Siegfried Muhlack (26 shared papers)Manfred Gerlach (6 shared papers)Hermann Russ (5 shared papers)Rejko Krüger (13 shared papers)
- Journals
- Journal of Neural Transmission (41 papers)Movement Disorders (12 papers)Clinical Neuropharmacology (11 papers)Expert Opinion on Pharmacotherapy (9 papers)Expert Opinion on Drug Metabolism & Toxicology (9 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Thomas Müller
245 papers receiving 6.6k citations
Thomas Müller's Hit Papers
Peers
Comparison fields: 5 of 145
- Neurology 3.7k
- Neurology 811
- Cellular and Molecular Neuroscience 1.7k
- Biological Psychiatry 150
- Rheumatology 573
Countries citing papers authored by Thomas Müller
This map shows the geographic impact of Thomas Müller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Müller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Müller more than expected).
Fields of papers citing papers by Thomas Müller
This network shows the impact of papers produced by Thomas Müller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Müller. The network helps show where Thomas Müller may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Müller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 250 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Interleukin-1β and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients Hit paper breakdown → | 1995 | 635 |
| 2 | 2005 | 431 | |
| 3 | 2006 | 215 | |
| 4 | 2003 | 153 | |
| 5 | 2015 | 139 | |
| 6 | 1998 | 138 | |
| 7 | 2009 | 116 | |
| 8 | 2000 | 107 | |
| 9 | 2008 | 102 | |
| 10 | 2004 | 97 | |
| 11 | 2013 | 95 | |
| 12 | 2019 | 87 | |
| 13 | 2004 | 84 | |
| 14 | 2002 | 83 | |
| 15 | 2012 | 81 | |
| 16 | 2014 | 81 | |
| 17 | 2001 | 72 | |
| 18 | 2006 | 67 | |
| 19 | 2009 | 65 | |
| 20 | 2017 | 63 |
About Thomas Müller
Thomas Müller is a scholar working on Neurology, Cellular and Molecular Neuroscience, Psychiatry and Mental health, Rheumatology and Cognitive Neuroscience, having authored 250 papers that have together received 6.8k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (156 papers), Neurological disorders and treatments (81 papers), Folate and B Vitamins Research (21 papers), Genetic Neurodegenerative Diseases (19 papers), Botulinum Toxin and Related Neurological Disorders (18 papers), Nuclear Receptors and Signaling (14 papers), Autism Spectrum Disorder Research (13 papers) and Multiple Sclerosis Research Studies (12 papers). The work is most often cited by research in Neurology (3.7k citations), Neurology (811 citations), Cellular and Molecular Neuroscience (1.7k citations), Biological Psychiatry (150 citations) and Rheumatology (573 citations). Thomas Müller has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include W. Kuhn, H. Przuntek, Peter Riederer, Dirk Woitalla, Siegfried Muhlack, Manfred Gerlach, Hermann Russ, Rejko Krüger, Thomas Büttner and Olaf Rieß. Their work appears in journals such as Journal of Neural Transmission, Movement Disorders, Clinical Neuropharmacology, Expert Opinion on Pharmacotherapy and Expert Opinion on Drug Metabolism & Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.